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Incroasc in levels of cstrogcn and progcstcronc during prcynoncy WIy affect intra-utctinc HIV-1 int’cction through their cffcct on matcnxtl 
immunocompctcnt cells. These hormones were examined for containing HIV-I production from ACH.2 lymphocytes and U I monocytes. N&her 
of the hormones has un cfl’ect on ACH-2. but with U I I the physiological concentrations (O.! ,ug-0, I 110) of progcstcronc und cstrogcn demonstrate 
significant inhibition of HIV-I r&w. Except for the highest dose of I pg//ml, the dose-rcsponsc to progcstcronc and cstrogcn was not corrclnted 
with the ncgntive intluencc on proliferation of both types ofcclls. The results suggest th;lt in vivo low doses of fcm;ilc sicroids ln;ly display specific 
antiviral activily in monocytes bu\ not in lymphocytes. 
HIV; Estrogen, Proycstcrone; Monocytc; Lymphocyte; Prcgmmcy 
1. INTRODUCTION 
The alteratium that occur in female hormone produc- 
tion during pregnancy may have an important impact 
on transmission of HIV-l from mother to child. Human 
trophoblasts composing the outer surface of the pla- 
centa produce a wide range of placental proteins and 
hormones, including estrogenic and progestational ster- 
oids. Although it is not clear how the increase in levels 
of estrogen and progesterone may affect HIV status, it 
undoubtedly nffects maternal virus-carrying immune 
cells. There is ample evidence of interaction of these 
hormones with lymphocytes and monocytic cells [1.3], 
the main circulating vectors of HIV-I. In this study two 
pregnancy hormones, progesterone and 17j%cstradioL 
were tested for their effect on HIV-I synthesis in virus- 
carrying monocytes and lymphocytes. 
2. MATERIALS AND METHODS 
The effect of pregnancy steroid hormones on HIV-I synthesis in 
lymphocytic ACH.2 and monocytic Ul cells (courtesy of AIDS Rc- 
search and Refcrcncc Reagent Program, NIH Rockville. MD; contri- 
butor: Thomas Folks) was meilsurcd by evaluating the lcvcls of ~24 
grog gene product or HIV-I in the culture Ruid ofcells (initial concen- 
tration 5 x IO5 cellu/ml) exposed for 3 days to serial ten-lbld dilutions 
(from I fiuS/rnl to 0.1 @ml) of 17@stradiol and progcstcronc (Sigma, 
St. Louis, MO). 
Viral production from infected cells resulting in rclctisc of HIV-I 
gag ~24 protein wils tested by ELISA. Viral core ~24 antigen ELISA 
kit wns purchased from Cellular Products (Buffalo, NY) and the asstly 
wtls performed according to manuftlcturcr’s instructions. The values 
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belLw 50 O.D. (cut off wlue = metin O.D, ol’wclls contuining culiure 
medium only) wcrc considcrcd as ncgativc values. 
The effect of prcgnanq hormones on prolifcrution of ACH-? nnd 
U I cells (5 x IO’ cells/ml) following 3 days ofcontinuous cxposurc w;~s 
mcusurcd simuIt;mcously by [“Hlthymidinc uptake. Cells were grown 
in RPM1 1640 medium with 10% l&l call‘scruni in the prescnrc or 
absence of log,,, conccnxttions of steroids for three days. Four h 
bcforc army. cells were pulsed with I ACi of [“Hlthymidinc (Amcr- 
shilm. Arlington Heights, IL). and incorporxion of the label was 
dctcrmincd by scintillation spectroscopy. 
Student’s ~.tcst wus used to conlpxe control vtilucs toobtained data 
from dcscribcd cxpcritncnts, 
3. RESULTS 
HIV- I-producing ACH-2 lymphocytes and U 1 mon- 
ocytes were incubated for three days in the presence of 
serial ten-fold dilutions of estrogen and progesterone. 
Fig, I shows, that except for 1 ,ug dose, the pregnancy 
hormones do not modify viral production from lympho- 
cytes. The dose-effect as tested by p24 ELlSA on Ul 
cells is shown in Fig , 2. The suppression of viral release 
was observed for all tested doses starting from the low- 
est concentration of 0.1 ng/ml. The action of both pro- 
gesterone and estrogen was characterized by a slope 
indicating a direct dose-response. 
To determine whether the observed inhibition of 
virus production was nor related to the growth suppres- 
sion of cells, we evaluated the effect of steroids on [.7H]- 
labeled thymidine incorporation (Fig. 2). There was no 
significant dose-dependence for progesterone and estro- 
gen except at the maximal dose of 1 ,@ml. It is, there- 
fore, likely that lower doses of estrogen and progcster- 
one have a specific antiviral effect that is unrelated to 
the suppression of cell proliferation. 
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Fig. I. EGci or progcsieronc (0) and cstroycn (0) on HIV-I production from lymphocyiic ACH -2 (4) and monocytic U I cells (B) following 3 
days ofconhuous cxposurc us mcdsured by ~24 ELISA. Typical rcsuhs from triplicate wells arc shown. Neither swroid hormone has any effiit 
on HIV-I rcplicalion in ACH-2 lyrnphocy~cs cxccpt for the cy\ostalic dose of I ~@~~I. Virus production from U I monocytcs in response LO estrogen 
cxposurc cxhibiu a dose-dcpendcn) mode. Thcrc is 90%-S% inhibhion across the lcstcd rang of estrogen from I yg to 0. I ng per ml. Progcstcronc 
appears LO display u more poicnl untiviral cffecl. According to ihc O.D, values thcrc is lOO%-73% rcduaion in ~24 lcvcls resuhinp from cxpoourc 
to I ,q+-0.1 ny of progcslcronc per nil of monocyic cuhurc. 
4. DISCUSSION 
Placental cells appear to resist HlV-1 infection, but 
the mechanism of such impregnability is not known. 
Our investigations [3,4] and studies by others [5] demon- 
strated that the infection of CD4-negative epithclial 
cells and placental trophoblasts results predominantly 
from physical contact with HLV-I infected lymphocytes 
or monocytes but not from exposure to free virus. 
Therefore, the possible mechanism of placental resis- 
tance could be attributed, at least in part, to the preven- 
tion of viral production from infected blood cells by 
secreted placental constituents like pregnancy 
hormones. 
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After establishment of the pregnancy, the levels of 
female steroids rise considerably. reaching a maximum 
of 0.5 pug and 1 pug per ml of plasma for estrogen and 
progesterone respectively, A number of observations 
support the concept that female steroids influence im- 
munity [1.2,6,7]. Estrogen receptors were identified on 
T-cytotoxic/suppressor but not on T-helper/inducer 
cells. Steroid hormones at pharmacological concentra- 
tions display a potent immunosuppressive effect on lym- 
phocytes in autologous immune reactions [8-l 11. Since 
most of the studies involving female steroids were con- 
ducted on T lymphocytes, little is known on the interac- 
tion of these hormones with monocytes. However, it is 
known that decidual maternal cells at the materno-fetal 
40 R r 
Fig. 2. Eiicsi of 3 days exposure LO progesterone (e) and cstrogcn (c) oh fJH]thymidinr uptake by .4CH-2 (A) and 1) I cells (B) as dclcrmincd in 
two separate experimems. lnhibhion of cellular growth is observable only at I pg concernration. SlaMical analysis of combined rauhs from the 
proliferation assays indicates 111s~ observed suppression of ~24 rclcasc from HIV-infected monocyla and lymphocytes ai concuntralions ofstcroid 
hormones below I p@l is not correlated LO the cell growth pattern us thcrc is no disccrniblc dose cffcc~. 
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interface are mainly composed of macrophages and not 
of T lymphocytes like ACH-2 [12.13]. The differential 
effect of steroids on the immune cells of monocyte/ mac- 
rophage lineage may he relevant o the fact that the 
antiviral action of progesterone and estrogen is demon- 
strated in monocytic ells and not on lymphocytes. Con- 
trary to the often ambiguous effect of estrogen on im- 
munity, progesterone has been consistently reported as 
a potent immunosuppressor 1141. Incidentally, in our 
study estrogen appears to inhibit the production of in- 
fectious virions to a lesser degree than progesterone. 
Complete inhibition of ~24 release by progesterone was 
observed at the noncytotoxic concentration of 0.1 ,~g/ 
ml, whereas a similar dose of estrogen contributed to 
75% inhibition. Considering the paucity of available 
anti-HIV drugs, these two hormones with established 
safety records of clinical use represent remarkably good 
candidates for clinical trials. 
Evidence of endocrine involvement in the course of 
HIV-I infection had been documented [I 5-171. How- 
ever, at the present ime the role of female hormones on 
viral status remains largely obscure [ 181. Our study in 
vitro supports the notion that female steroid hormones 
control the replication of HIV-I in monocytes and 
therefore, may contribute to the prevention of HIV-I 
transmission from mother to child. The observations 
described here urge for examining the antiviral role of 
pregnancy hormones in vivo. 
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